This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Template:SubstanceBox/Gabapentin: Difference between revisions
>Standard Fix copy-paste error for peak duration |
>Isaak Annotate bioavailability correctly |
||
| (One intermediate revision by one other user not shown) | |||
| Line 54: | Line 54: | ||
|OralROA_Collapsed=false | |OralROA_Collapsed=false | ||
|OralROA_Caption= | |OralROA_Caption= | ||
|OralROA_Bioavailability=27% - 60%<ref> | |OralROA_Bioavailability=[[Oral min bioavailability::27]]% - [[Oral max bioavailability::60]]%<ref name="NeurotoninMedScape">{{Citation | title=Neurontin, Gralise (gabapentin) dosing, indications, interactions, adverse effects, and more | url=https://reference.medscape.com/drug/neurontin-gralise-gabapentin-343011}}</ref> | ||
|OralROA_Threshold=[[Oral threshold dose::200]] [[Oral dose units::mg]] | |OralROA_Threshold=[[Oral threshold dose::200]] [[Oral dose units::mg]] | ||
|OralROA_Light=[[Oral min light dose::200]] - [[Oral max light dose::900]] mg | |OralROA_Light=[[Oral min light dose::200]] - [[Oral max light dose::900]] mg | ||